6533b7d8fe1ef96bd126a58a
RESEARCH PRODUCT
Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The “Bayes' Syndrome-HF” study
Julio NúñezMarta De AntonioEvelyn Santiago-vacasManuel Martínez-sellésElisabet ZamoraAdrian BaranchukPedro MolinerJosep LupónMar DomingoAntoni Bayés-de-lunaLuis Alberto Escobar-robledoAntoni Bayes-genisGermán Cedielsubject
Malemedicine.medical_specialtyAll-cause deathEnfermedad cardiovascularAdvanced interatrial blockNew-onset atrial fibrillationHeart failure030204 cardiovascular system & hematologyFibrilación auricularBrain IschemiaElectrocardiography03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineAtrial FibrillationmedicineClinical endpointHumansInteratrial BlockSinus rhythmProspective Studies030212 general & internal medicineStrokeAgedSistema cardiovascularAged 80 and overHeart FailureProportional hazards modelbusiness.industryAtrial fibrillationInteratrial BlockSyndromeMiddle Agedmedicine.diseaseStrokeHeart failureCardiologyFemaleCardiopatía coronariaObservational studyInfarto de miocardioCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesdescription
Advanced interatrial block (IAB) is characterized by a prolonged (≥120 ms) and bimodal P wave in the inferior leads. The association between advanced IAB and atrial fibrillation (AF) is known as “Bayes' Syndrome”, and there is scarce information about it in heart failure (HF). We examined the prevalence of IAB and whether advanced IAB could predict new-onset AF and/or stroke in HF patients. Methods and results: The prospective observational “Bayes' Syndrome-HF” study included consecutive outpatients with chronic HF. The primary endpoints were new-onset AF, ischemic stroke, and the composite of both. A secondary endpoint included all-cause death alone or in combination with the primary endpoint. Comprehensive multivariable Cox regression analyses were performed. Among 1050 consecutive patients, 536 (51.0%) were in sinus rhythm, 464 with a measurable P wave are the focus of this study. Two-hundred and sixty patients (56.0%) had normal atrial conduction, 95 (20.5%) partial IAB, and 109 (23.5%) advanced IAB. During a mean follow-up of 4.5 ± 2.1 years, 235 patients experienced all-cause death, new-onset AF, or stroke. In multivariable comprehensive Cox regression analyses, advanced IAB was associated with new-onset AF (HR 2.71 [1.61–4.56], P < 0.001), ischemic stroke (HR 3.02 [1.07–8.53], P = 0.04), and the composite of both (HR 2.42 [1.41–4.15], P < 0.001). Conclusions: In patients with HF advanced IAB predicts new-onset AF and ischemic stroke. Future studies must assess whether anticoagulant treatment in Bayes' Syndrome leads to better outcomes in HF. Sin financiación 3.471 JCR (2018) Q2, 48/136 Cardiac & Cardiovascular Systems 0.990 SJR (2018) Q2, 91/365 Cardiology and Cardiovascular Medicine No data IDR 2018 UEM
year | journal | country | edition | language |
---|---|---|---|---|
2018-01-01 | International Journal of Cardiology |